Breaking News Instant updates and real-time market news.

DLB

Dolby

$62.94

0.54 (0.87%)

, NKE

Nike

$77.80

0.5 (0.65%)

11:31
07/10/18
07/10
11:31
07/10/18
11:31

Dolby names Todd Pendleton as Chief Marketing Officer

Dolby Laboratories (DLB) announced the appointment of Todd Pendleton as its Senior Vice President and Chief Marketing Officer. During his 15-years at Nike (NKE) in Marketing, Pendleton held country, regional, and global leadership roles working across North America, Europe, and Asia.

DLB

Dolby

$62.94

0.54 (0.87%)

NKE

Nike

$77.80

0.5 (0.65%)

  • 16

    Jul

  • 17

    Jul

  • 18

    Jul

  • 19

    Jul

DLB Dolby
$62.94

0.54 (0.87%)

01/16/18
RILY
01/16/18
DOWNGRADE
Target $63
RILY
Neutral
Dolby downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Eric Wood downgraded Dolby Laboratories to Neutral saying the risk/reward is more balanced following the recent share rally.
04/03/18
DOTC
04/03/18
NO CHANGE
Target $75
DOTC
Buy
Dolby investments have reached payoff stage, says Dougherty
Dougherty analyst Steven Frankel said Dolby is battling a perception that it is tied to legacy technologies, but he believes investors have missed a resurging growth story as the company's multi-year investments in new technologies have reached the payoff stage. The idea of Dolby being a double-digit revenue grower "has gone from aspirational when first trotted out by management a couple of years ago to something that looks achievable," contends Frankel, who reiterated a Buy rating and $75 price target on Dolby shares.
04/06/18
WBLR
04/06/18
NO CHANGE
WBLR
Outperform
Dolby relationship with Samsung may be strengthening, says William Blair
William Blair analyst Ralph Schackart points out that on February 25, the Samsung Galaxy S9/S9+ product line added Dolby Atmos to its smartphones. Dolby Atmos was launched in 2012 with a focus on the movie theater end-market, Schackart tells investors in a research note. The analyst views the development as potentially early evidence that the "historically rocky Samsung/Dolby relationship may be strengthening." He estimates the Atmos opportunity for Dolby in 2018 at roughly $8M in sales and about 6c in earnings per share. Schackart keeps an Outperform rating on Dolby.
04/25/18
WBLR
04/25/18
NO CHANGE
WBLR
Outperform
Dolby shares can reach mid-$80s over next 12 months, says William Blair
William Blair analyst Ralph Schackart attributes the post-earnings weakness in Dolby share to investors being disappointed by the "relatively weak" Q3 revenue guidance as well as foreign exchange-affected operating expense guidance. The analyst, however, sees optimism from management as a result of increasing full-year top-line guidance by $10M, despite a narrow beat on revenue this quarter. New products are still on pace to double in revenue in fiscal 2018, from a 2017 base of $60M, Schackart tells investors in a research note. He believes the shares over the next 12 months can reach the mid-$80s. The analyst maintains an Outperform rating on Dolby.
NKE Nike
$77.80

0.5 (0.65%)

06/29/18
STFL
06/29/18
NO CHANGE
Target $90
STFL
Buy
Nike business model shift showing early benefits, says Stifel
Stifel analyst Jim Duffy noted that Nike's Q4 revenue and gross margin "handily" topped estimates and that its FY19 reported revenue growth guidance also beat expectations, which he calls early evidence of its business model innovation and execution. While he expects Nike's transition to a higher margin, higher return model will take time, he is encouraged by the early signs of progress and thinks the shift will support a premium multiple compared to historical levels, Duffy tells investors. He maintains a Buy rating on Nike and raised his price target on the shares to $90 from $87.
06/29/18
BERN
06/29/18
NO CHANGE
Target $84
BERN
Outperform
Nike price target raised to $84 from $76 at Bernstein
Bernstein analyst Jamie Merriman reiterated an Outperform rating on Nike and raised her price target to $84 from $76 following the company's Q4 results based on her belief that product innovation will continue to drive long-term revenue growth and the mix shift under way to Direct-to-Consumer will lead to margin upside, forecasting a 17% EPS CAGR over the next five years. In a research note to investors, Merriman contends that over the last few months, optimism that Nike has "righted the ship" has emerged, and that momentum is expected to continue into 2019 with the ramp of products like Vapormax and Epic React, the rollout of Nike's digital initiatives internationally and events like the World Cup.
06/29/18
JEFF
06/29/18
NO CHANGE
Target $75
JEFF
Buy
Nike shares remain expensive despite strong Q4, says Jefferies
Jefferies analyst Randal Konik says that while Nike last night reported strong Q4 results, the shares remain expensive. The analyst raised his price target for the stock to $75 from $68 and reiterates a Hold rating on the name. Konik continues to like Foot Locker (FL) as a less expensive way to play Nike, and Under Armour (UAA) as a better way to play a strengthening athletic space.
06/29/18
FBCO
06/29/18
NO CHANGE
Target $90
FBCO
Outperform
Nike price target raised to $90 from $78 at Credit Suisse
Credit Suisse analyst Michael Binetti reiterated an Outperform rating on Nike and raised his price target to $90 from $78 following the company's Q4 results, telling investors in a research note that the results signal that several years of bloated inventories, lackluster innovation and market share losses are now clearly inflecting. Binetti thinks Nike is well positioned to monetize reversing multi-year share losses to drive upside to guidance, but notes that Nike's transformation acceleration to more of a direct/digital retailer will put significant upward pressure on the economics of the business vs. historical levels.

TODAY'S FREE FLY STORIES

VFC

VF Corp.

$92.95

3.74 (4.19%)

, EXPE

Expedia

$125.50

-2.34 (-1.83%)

07:30
07/23/18
07/23
07:30
07/23/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

VFC

VF Corp.

$92.95

3.74 (4.19%)

EXPE

Expedia

$125.50

-2.34 (-1.83%)

PVG

Pretium Resources

$8.37

0.115 (1.39%)

TSN

Tyson Foods

$64.14

-0.76 (-1.17%)

SN

Sanchez Energy

$4.68

-0.14 (-2.90%)

NYCB

New York Community Bancorp

$11.41

-0.025 (-0.22%)

AN

AutoNation

$48.59

-0.75 (-1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 01

    Aug

  • 07

    Aug

  • 28

    Oct

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

07:29
07/23/18
07/23
07:29
07/23/18
07:29
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$104.35

-0.3 (-0.29%)

07:29
07/23/18
07/23
07:29
07/23/18
07:29
Recommendations
Wix.com analyst commentary  »

Wix.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 05

    Sep

  • 06

    Sep

FOXA

21st Century Fox

$46.01

-0.54 (-1.16%)

07:29
07/23/18
07/23
07:29
07/23/18
07:29
Conference/Events
21st Century Fox to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

SNAP

Snap

$13.27

-0.155 (-1.16%)

, SQ

Square

$70.41

0.11 (0.16%)

07:28
07/23/18
07/23
07:28
07/23/18
07:28
Periodicals
Snap to shutdown Snapcash, end partnership with Square, TechCrunch reports »

Snap (SNAP) will end its…

SNAP

Snap

$13.27

-0.155 (-1.16%)

SQ

Square

$70.41

0.11 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 07

    Aug

  • 15

    Aug

  • 16

    Aug

EVER

EverQuote

$17.99

0.43 (2.45%)

07:28
07/23/18
07/23
07:28
07/23/18
07:28
Initiation
EverQuote initiated  »

EverQuote initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

VFC

VF Corp.

$92.95

3.74 (4.19%)

07:27
07/23/18
07/23
07:27
07/23/18
07:27
Recommendations
VF Corp. analyst commentary  »

VF Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$182.65

0.49 (0.27%)

, P

Pandora

$8.20

0.005 (0.06%)

07:27
07/23/18
07/23
07:27
07/23/18
07:27
Initiation
Spotify, Pandora initiated  »

Spotify initiated with a…

SPOT

Spotify

$182.65

0.49 (0.27%)

P

Pandora

$8.20

0.005 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Aug

  • 14

    Aug

SHOP

Shopify

$171.72

0.04 (0.02%)

07:27
07/23/18
07/23
07:27
07/23/18
07:27
Recommendations
Shopify analyst commentary  »

Shopify price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

BIIB

Biogen

$358.72

0.55 (0.15%)

07:26
07/23/18
07/23
07:26
07/23/18
07:26
Recommendations
Biogen analyst commentary  »

Biogen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

07:25
07/23/18
07/23
07:25
07/23/18
07:25
General news
FX Update: The Dollar recovered losses »

FX Update: The Dollar…

GDDY

GoDaddy

$78.49

0.25 (0.32%)

07:24
07/23/18
07/23
07:24
07/23/18
07:24
Recommendations
GoDaddy analyst commentary  »

GoDaddy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

EVER

EverQuote

$17.99

0.43 (2.45%)

07:23
07/23/18
07/23
07:23
07/23/18
07:23
Initiation
EverQuote initiated  »

EverQuote initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

WCG

WellCare

$256.13

0.545 (0.21%)

07:22
07/23/18
07/23
07:22
07/23/18
07:22
Initiation
WellCare initiated  »

WellCare initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

MOH

Molina Healthcare

$106.16

0.64 (0.61%)

07:20
07/23/18
07/23
07:20
07/23/18
07:20
Initiation
Molina Healthcare initiated  »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 21

    Aug

07:20
07/23/18
07/23
07:20
07/23/18
07:20
General news
Treasury Market Outlook: Treasury yields have dipped lower »

Treasury Market Outlook:…

CNC

Centene

$135.45

0.175 (0.13%)

07:19
07/23/18
07/23
07:19
07/23/18
07:19
Initiation
Centene initiated  »

Centene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 10

    Aug

  • 23

    Oct

  • 14

    Dec

OMER

Omeros

$19.63

-0.42 (-2.09%)

07:19
07/23/18
07/23
07:19
07/23/18
07:19
Hot Stocks
Omeros initiates sales of Omidria in Europe, satisfies 'sunset clause' »

Omeros announced initial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOVE

Lovesac

$20.84

0.07 (0.34%)

07:19
07/23/18
07/23
07:19
07/23/18
07:19
Initiation
Lovesac initiated  »

Lovesac initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

07:17
07/23/18
07/23
07:17
07/23/18
07:17
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$45.69

-0.5 (-1.08%)

07:16
07/23/18
07/23
07:16
07/23/18
07:16
Conference/Events
21st Century Fox to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

SESN

Sesen Bio

$1.86

-0.05 (-2.62%)

07:16
07/23/18
07/23
07:16
07/23/18
07:16
Initiation
Sesen Bio initiated  »

Sesen Bio initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCI

Intra-Cellular

$20.81

0.19 (0.92%)

07:14
07/23/18
07/23
07:14
07/23/18
07:14
Hot Stocks
Intra-Cellular announces publication highlighting ITI-214 »

Intra-Cellular Therapies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYB

RYB Education

$21.21

-0.33 (-1.53%)

07:14
07/23/18
07/23
07:14
07/23/18
07:14
Initiation
RYB Education initiated  »

RYB Education initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$10.85

-0.575 (-5.03%)

07:13
07/23/18
07/23
07:13
07/23/18
07:13
Hot Stocks
Hi-Crush Partners raises quarterly distribution to 75c per unit »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.